Tag: schedule III

**UPDATE ** As of April 30th, 2024, the United States Drugs Enforcement Agency (DEA), under the auspices of the US Department of Justice, there has been implemented a new policy recommendation that will result in cannabis being rescheduled to schedule III, alongside ketamine and anabolic steroids. Our newest article on this subject will go live…